Editas Medicine Inc.
EDIT | NASDAQ
$2.85
+$0.02 (+0.71%)
Sep 22, 2026, 1:28 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.14 | -0.44 | -5.01 | -2.76 | -9.32 | -35.41 |
PEG Ratio | 0.03 | -0.01 | 0.14 | -0.22 | -0.21 | 1.78 |
PS Ratio | 4.49 | 3.24 | 9.85 | 30.90 | 70.28 | 45.29 |
PB Ratio | 6.67 | 0.78 | 2.20 | 1.69 | 3.24 | 10.44 |
P/FCF Ratio | -1.10 | -0.48 | -5.62 | -3.36 | -10.45 | -21.97 |
P/OCF Ratio | -1.10 | -0.50 | -5.82 | -3.43 | -10.96 | -22.85 |
OCF/S Ratio | -407.80 | -650.75 | -169.19 | -899.70 | -641.26 | -198.21 |
Debt / Equity Ratio | 2.81 | 0.26 | 0.14 | 0.12 | 0.05 | 0.07 |
Quick Ratio | 3.54 | 3.75 | 5.39 | 5.94 | 10.82 | 7.20 |
Current Ratio | 3.54 | 3.75 | 5.39 | 5.94 | 10.82 | 7.20 |
Asset Turnover | 0.22 | 0.09 | 0.16 | 0.04 | 0.04 | 0.16 |
Interest Coverage | -16.10 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -586.56% | -176.57% | -43.89% | -61.12% | -34.77% | -29.47% |
Return on Assets | -85.81% | -69.41% | -30.70% | -42.86% | -28.41% | -20.25% |
Return on Invested Capital | -65.65% | -90.01% | -36.77% | -48.56% | -30.14% | -25.87% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | -516.60% | 92.24% | 67.85% | 80.22% | -74.13% |
Net Profit Margin | -395.01% | -733.72% | -196.13% | -1.12K% | -753.61% | -127.82% |
Pretax Profit Margin | -395.01% | -733.72% | -196.13% | -1.12K% | -753.61% | -127.82% |
Operating Profit Margin | -245.15% | -777.22% | -216.56% | -1.15K% | -756.13% | -148.61% |
FCF Margin | -409.30% | -678.07% | -175.23% | -920.59% | -672.49% | -206.11% |
EBITDA Margin | -366.76% | -721.39% | -188.36% | -1.09K% | -733.83% | -144.25% |
Add to Watchlist
Select watchlists to add or remove EDIT